WallStreetZenWallStreetZen

NASDAQ: BBOT
Bridgebio Oncology Therapeutics Inc Stock Ownership - Who owns Bridgebio Oncology Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bridgebio Oncology Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Yong BenMed2026-10-011,047$3.94
$4.13kSell
Idan ElmelechCFO;COO2026-10-01343$3.94
$1.35kSell
Marc CoboPAO2026-10-01126$3.94
$496.44Sell
Pedro BeltranCEO;Pres2026-10-011,047$3.94
$4.13kSell
Marc CoboPAO2026-09-10203$5.52
$1.12kSell
Yong BenChief Med Dev Officer2026-07-011,047$7.80
$8.17kSell
Pedro BeltranPresident and CEO2026-07-011,047$7.80
$8.17kSell
Idan ElmelechCOO Principal Financial Ofcr2026-07-01343$7.80
$2.68kSell
Marc CoboPrincipal Accounting Officer2026-07-01125$7.80
$975.00Sell
Uneek MehraInsider2026-04-01524$9.03
$4.73kSell

1 of 2

BBOT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BBOT insiders and whales buy or sell their stock.

BBOT Shareholders

What type of owners hold Bridgebio Oncology Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bihua Chen23.43%18,782,194$51.09MInsider
Bridgebio Pharma LLC18.20%14,589,846$39.68MInsider
Helix Holdings II LLC0.63%509,000$1.38MInsider
Pedro Beltran0.05%43,529$118.40kInsider
Yong Ben0.05%43,529$118.40kInsider
Mark C. McKenna0.04%30,000$81.60kInsider
John P. Schmid0.04%30,000$81.60kInsider
Albert A. Holman Iii0.04%30,000$81.60kInsider
Uneek Mehra0.03%22,806$62.03kInsider
Cormor0.02%17,879$48.63kInstitution

1 of 3

BBOT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BBOT0.07%42.54%Net SellingNet Selling
ALEC0.08%43.66%Net SellingNet Selling
SLGL0.04%86.12%Net BuyingNet Buying
MGNX0.08%37.82%Net SellingNet Buying
PLX0.01%99.99%Net Buying
View Top Biotech Stocks

Bridgebio Oncology Therapeutics Stock Ownership FAQ

Who owns Bridgebio Oncology Therapeutics?

Bridgebio Oncology Therapeutics (NASDAQ: BBOT) is owned by 0.07% institutional shareholders, 42.54% Bridgebio Oncology Therapeutics insiders, and 57.38% retail investors. Bihua Chen is the largest individual Bridgebio Oncology Therapeutics shareholder, owning 18.78M shares representing 23.43% of the company. Bihua Chen's Bridgebio Oncology Therapeutics shares are currently valued at $51.09M.

If you're new to stock investing, here's how to buy Bridgebio Oncology Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.